Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Meloxoral   
Auth. number : EU/2/10/111
Active substance : Meloxicam
ATC: Anatomical main group: QM - Musculo-skeletal system
Therapeutic subgroup: QM01 - Antiinflammatory and antirheumatic products
Pharmacological subgroup: QM01A - Antiinflammatory and antirheumatic products, non-steroids
Chemical subgroup: QM01AC - Oxicams
Chemical substance: QM01AC06 - Meloxicam
(See WHO ATCvet Index)
Indication: Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.
Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in cats.
Marketing Authorisation Holder: Le Vet B.V.
Wilgenweg 7, NL-3421 TV Oudewater, Nederland
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/11/2010 Centralised - Authorisation EMEA/V/C/151 (2010)8303 of 19/11/2010
07/04/2011 Centralised - Variation EMEA/V/C/151/IB/1G
Updated with Decision(2011)7798 of 24/10/2011
13/05/2011 Centralised - Variation EMEA/V/C/151/IB/2
Updated with Decision(2011)7798 of 24/10/2011
04/07/2011 Centralised - Variation EMEA/V/C/151/IB/3
Updated with Decision(2011)7798 of 24/10/2011
26/10/2011 Centralised - Variation (2011)7798 of 24/10/2011
04/10/2013 Centralised - Variation EMEA/V/C/151/IB/4
Updated with Decision(2014)7152 of 30/09/2014
02/10/2014 Centralised - Yearly update (2014)7152 of 30/09/2014